These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30606139)

  • 1. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.
    Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R
    BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.
    Banelli B; Bonassi S; Casciano I; Mazzocco K; Di Vinci A; Scaruffi P; Brigati C; Allemanni G; Borzì L; Tonini GP; Romani M
    Int J Cancer; 2010 Feb; 126(3):656-68. PubMed ID: 19626586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of delta-like gene and protein in neuroblastoma, ganglioneuroblastoma and ganglioneuroma.
    Hsiao CC; Huang CC; Sheen JM; Tai MH; Chen CM; Huang LL; Chuang JH
    Mod Pathol; 2005 May; 18(5):656-62. PubMed ID: 15605081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.
    Tabyaoui I; Tahiri-Jouti N; Serhier Z; Bennani-Othmani M; Sibai H; Itri M; Benchekroun S; Zamiati S
    Diagn Pathol; 2013 Feb; 8():39. PubMed ID: 23445749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
    Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of peripheral neuroblastic tumors].
    Wang L; He LJ; Shimada H
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
    Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
    Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
    Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
    Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
    Lonergan GJ; Schwab CM; Suarez ES; Carlson CL
    Radiographics; 2002; 22(4):911-34. PubMed ID: 12110723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors.
    Ikuno N; Shimokawa I; Nakamura T; Ishizaka Y; Ikeda T
    Pathol Res Pract; 1995 Mar; 191(2):92-9. PubMed ID: 7567689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.
    Wilzén A; Krona C; Sveinbjörnsson B; Kristiansson E; Dalevi D; Øra I; De Preter K; Stallings RL; Maris J; Versteeg R; Nilsson S; Kogner P; Abel F
    Mol Cancer; 2013 Jul; 12(1):70. PubMed ID: 23835063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.
    Wang M; Zhou C; Cai R; Li Y; Gong L
    Diagn Pathol; 2013 Jan; 8():5. PubMed ID: 23320395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
    Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
    Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of Oct4 and Nanog in neuroblastoma.
    Monajemzadeh M; Soleimani V; Vasei M; Koochakzadeh L; Karbakhsh M
    APMIS; 2014 Sep; 122(9):734-41. PubMed ID: 24320714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
    Hicks MJ; Mackay B
    Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.